Get started
Annexon, Inc.Annexon, Inc.Annexon, Inc.

Annexon, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

ANNX chart


Full chart

ANNX upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪562.81 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.04 USD
Net income (FY)
‪−134.24 M‬ USD
Revenue (FY)
0.00 USD
Shares float
‪89.48 M‬
Beta (1Y)
1.83

Employees


Employees (FY)
71
Change (1Y)
−9 −11.25%
Revenue / Employee (1Y)
0.00 USD
Net income / Employee (1Y)
‪−1.89 M‬ USD

About Annexon, Inc.


Sector
Health Technology
CEO
Douglas Love
Headquarters
Brisbane
Website
annexonbio.com
Founded
2011
FIGI
BBG007QVDFG2
Annexon, Inc. is a clinical-stage biopharmaceutical company, which develops a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, eye and brain. It offers drugs that control or target huntington’s and alzheimer’s disease, multiple sclerosis, glaucoma, parkinson’s disease, and spinal muscular atrophy. The company was founded by Ben Barres and Arnon Rosenthal on March 3, 2011 and is headquartered in Brisbane, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

ANNX news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of ANNX is 5.23 USD — it has increased by 0.96% in the past 24 hours. Watch Annexon, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Annexon, Inc. stocks are traded under the ticker ANNX.
ANNX stock has risen by 5.60% compared to the previous week, the month change is a 1.93% rise, over the last year Annexon, Inc. has showed a 41.73% increase.
We've gathered analysts' opinions on Annexon, Inc. future price: according to them, ANNX price has a max estimate of 30.00 USD and a min estimate of 9.00 USD. Watch ANNX chart and read a more detailed Annexon, Inc. stock forecast: see what analysts think of Annexon, Inc. and suggest that you do with its stocks.
ANNX reached its all-time high on Feb 22, 2021 with the price of 38.01 USD, and its all-time low was 1.57 USD and was reached on Oct 16, 2023. View more price dynamics on ANNX chart.
See other stocks reaching their highest and lowest prices.
ANNX stock is 6.18% volatile and has beta coefficient of 1.83. Track Annexon, Inc. stock price on the chart and check out the list of the most volatile stocks — is Annexon, Inc. there?
Yes, you can track Annexon, Inc. financials in yearly and quarterly reports right on TradingView.
Annexon, Inc. is going to release the next earnings report on Mar 20, 2025. Keep track of upcoming events with our Earnings Calendar.
ANNX earnings for the last quarter are −0.25 USD per share, whereas the estimation was −0.26 USD resulting in a 3.16% surprise. The estimated earnings for the next quarter are −0.27 USD per share. See more details about Annexon, Inc. earnings.
Annexon, Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
ANNX net income for the last quarter is ‪−34.82 M‬ USD, while the quarter before that showed ‪−29.61 M‬ USD of net income which accounts for −17.61% change. Track more Annexon, Inc. financial stats to get the full picture.
No, ANNX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 25, 2024, the company has 71.00 employees. See our rating of the largest employees — is Annexon, Inc. on this list?
Like other stocks, ANNX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Annexon, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Annexon, Inc. technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Annexon, Inc. stock shows the sell signal. See more of Annexon, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.